Twist Bioscience Number Of Shares Shorted vs. Current Valuation
| TWST Stock | USD 49.18 0.86 1.78% |
For Twist Bioscience profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Twist Bioscience to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Twist Bioscience Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Twist Bioscience's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Twist Bioscience Corp over time as well as its relative position and ranking within its peers.
Twist |
Twist Bioscience's Revenue Breakdown by Earning Segment
Check out World Market Map.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.60) | Revenue Per Share 5.119 | Quarterly Revenue Growth 0.278 | Return On Assets (0.16) | Return On Equity (0.38) |
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Twist Bioscience Corp Current Valuation vs. Number Of Shares Shorted Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Twist Bioscience's current stock value. Our valuation model uses many indicators to compare Twist Bioscience value to that of its competitors to determine the firm's financial worth. Twist Bioscience Corp is rated third in number of shares shorted category among its peers. It is rated below average in current valuation category among its peers reporting about 305.98 of Current Valuation per Number Of Shares Shorted. Comparative valuation analysis is a catch-all technique that is used if you cannot value Twist Bioscience by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Twist Current Valuation vs. Number Of Shares Shorted
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Twist Bioscience |
| = | 8.75 M |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Twist Bioscience |
| = | 2.68 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Twist Current Valuation vs Competition
Twist Bioscience Corp is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 647.67 Billion. Twist Bioscience adds roughly 2.68 Billion in current valuation claiming only tiny portion of equities under Health Care industry.
Twist Bioscience Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Twist Bioscience, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Twist Bioscience will eventually generate negative long term returns. The profitability progress is the general direction of Twist Bioscience's change in net profit over the period of time. It can combine multiple indicators of Twist Bioscience, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -522 K | -495.9 K | |
| Net Interest Income | 15.3 M | 16.1 M | |
| Interest Income | 15.3 M | 16.1 M | |
| Operating Income | -220.8 M | -209.8 M | |
| Net Loss | -208.7 M | -219.2 M | |
| Income Before Tax | -208.2 M | -218.6 M | |
| Total Other Income Expense Net | 12.7 M | 13.3 M | |
| Net Loss | -196.1 M | -186.3 M | |
| Net Loss | -208.7 M | -219.2 M | |
| Income Tax Expense | 560 K | 588 K | |
| Non Operating Income Net Other | 7.6 M | 7.9 M | |
| Change To Netincome | 94.7 M | 99.4 M | |
| Net Loss | (3.60) | (3.78) | |
| Income Quality | 0.31 | 0.29 | |
| Net Income Per E B T | 1.00 | 1.10 |
Twist Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Twist Bioscience. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Twist Bioscience position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Twist Bioscience's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Twist Bioscience without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Use Investing Themes to Complement your Twist Bioscience position
In addition to having Twist Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Most Shorted Equities Thematic Idea Now
Most Shorted Equities
Dynamically calculated list of top equities currently trending upward via a buy-out by investors. The Most Shorted Equities theme has 221 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Most Shorted Equities Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Twist Stock Analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.